When the Bush administration came in and Todd Dickinson left his post as director of the US Patent and Trademark Office, there were approximately 10,000 outstanding gene-based patent applications. Early patents of this type tended to be full-length sequences; now, most focus on ESTs or SNPs. Since April, Dickinson hangs his shingle at the law firm Howrey Simon Arnold and White, where he’s a partner dealing with IP. GT’s Meredith Salisbury caught up with him to find out about guidelines, evaluations, and patent pooling.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.